Patent · US Active

Rapamycin assay

US8039600B2 · kind B2 · utility

3Cited by

13References

1Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Richard Sedrani · Basel, CH
Valerie Ryffel · Allschwil, CH

Key dates

Filing date	Aug 20, 2001
Grant date	Oct 18, 2011
Priority date	—
Expiry date	Nov 2, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K16/1292
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Monoclonal antibodies to rapamycin and to 40-O-alkylated derivatives of rapamycin are provided, together with novel haptens, immunogenic conjugates, and processes for making them and assay kits for using them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.